Arbovirus Testing Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The arbovirus
testing market was valued at 1.1 billion dollars worldwide in 2023 and
is expected to expand at a compound annual growth rate (CAGR) of 7.1% over the
course of the forecast period. The market's demand is being driven by rising
healthcare costs and growing awareness of tropical diseases like dengue and
chikungunya that are caused by arboviruses but are ignored by the government.
The primary
driver of the market's notable expansion is growing public awareness of chronic
illnesses. The need for diagnostics, therapies, and vaccinations is being
driven by the rise in Zika and West Nile virus incidence. Favorable conditions
for vector breeding are being created by urbanization, deforestation, and
global warming.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/arbovirus-testing-market
Growth
Drivers
Public health
campaigns and investments in mosquito control strategies are becoming more well
known. The need for preventative measures and pre-travel vaccines is being
driven by travel-related hazards. The market is experiencing high demand due to
ongoing efforts to create broad-spectrum antivirals for alphaviruses and
flaviviruses.
Urbanization also has a big impact since these vectors thrive in crowded, dirty
places without proper sanitation. Furthermore, the expansion of international
travel and globalization make it easier for these viruses to traverse national
boundaries and infect new areas and populations.
The increasing
prevalence of arboviral infections, including dengue, Zika, chikungunya, and
West Nile virus, is one of the main causes. Climate change expands the range of
habitats for vectors like mosquitoes by producing warmer and more humid
conditions that are favorable to their growth.
Segmentation
Infectious
Diseases IVD Product
· Instruments
§ MRSA
§ Streptococcus
§ Clostridium
Difficile
§ VRE
§ CRE
§ Respiratory
Virus
§ Candida
§ TB
and Drug-resistant TB
§ Gastro-intestinal
Panel Testing
§ Chlamydia
§ Gonorrhea
§ HPV
§ HIV
§ Hepatitis
C
§ Hepatitis
B
§ COVID-19
§ Others Infectious
Diseases
o Reagents
§ MRSA
§ Streptococcus
§ Clostridium
Difficile
§ VRE
§ CRE
§ Respiratory
Virus
§ Candida
§ TB
and Drug-resistant TB
§ Gastro-intestinal
Panel Testing
§ Chlamydia
§ Gonorrhea
§ HPV
§ HIV
§ Hepatitis
C
§ Hepatitis
B
§ COVID-19
§ Others Infectious
Diseases
o Software
Services
§ MRSA
§ Streptococcus
§ Clostridium
Difficile
§ VRE
§ CRE
§ Respiratory
Virus
§ Candida
§ TB
and Drug-resistant TB
§ Gastro-intestinal
Panel Testing
§ Chlamydia
§ Gonorrhea
§ HPV
§ HIV
§ Hepatitis
C
§ Hepatitis
B
§ COVID-19
§ Others Infectious
Diseases
Infectious
Diseases IVD Technology
· Immunoassay
· Molecular
Diagnostics
o Polymerase
Chain Reaction (PCR)
o In
Situ Hybridization
o Isothermal
Nucleic Acid Amplification Technology (INAAT)
o Chips
and Microarrays
o Sequencing
& NGS
o Transcription
Mediated Amplification
· Others
· Microbiology
Infectious
Diseases IVD Application
· MRSA
· Streptococcus
· Clostridium
Difficile
· VRE
· CRE
· Respiratory
Virus
· Candida
· TB
and Drug-resistant TB
· Gastro-intestinal
Panel Testing
· Chlamydia
· Gonorrhea
· HPV
· HIV
· Hepatitis
C
· Hepatitis
B
· COVID-19
· Others Infectious
Diseases
Infectious
Diseases IVD Test Location
· Point
of Care
· Central
Laboratories
· Others
By Region
· Asia-Pacific
· North
America
· Latin
America
· Middle
East and Africa
· Europe
Key
Players
· Agilent
Technologies, Inc.
· Thermo
Fisher Scientific.
· NovaTec
Immundiagnostica GmbH.
· Euroimmun
AG.
· Abbott
Laboratories
· DiaSorin
S.p.A.
· Hologic
Inc.
· Siemens
Healthcare GmbH
· Inverness
Medical Innovations
· Chembio
Diagnostics
· Ortho
Clinical Diagnostics
· Abbott
Laboratories
· Alere
Inc.
· HoffmannLa
Roche Ltd
· Trinity
Biotech Plc
· Thermo
Fisher Scientific Inc.
· QIAGEN
N.V.
· BioRad
Laboratories
· Danaher
Corporation
· Other
Players
For More Information about this Report @
https://www.xresearch.biz/shop/arbovirus-testing-market
About Us: -
xResearch
is a market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment